TY - JOUR
T1 - Anal fistula plug is a valid alternative option for the treatment of complex anal fistula in the long term
AU - Lenisa, Leonardo
AU - Espìn-Basany, Eloy
AU - Rusconi, Andrea
AU - Mascheroni, Luigi
AU - Escoll-Rufino, Jordi
AU - Lozoya-Trujillo, Roberto
AU - Vallribera-Valls, Francesc
AU - Mégevand, Jacques
N1 - Funding Information:
Written informed consent with explicit mention of the novel characteristics of the plug procedure was obtained. The study was self-funded, and no financial support was received. “Success” was clinically defined as the absence of any discharge or swelling, with the internal opening closed at anoscopy evaluation and with the external opening closed at perineal exam. Healed patients were randomly submitted to endo-anal ultrasound for exploratory purposes, but the results of this evaluation did not impact the definition of success.
PY - 2010/12
Y1 - 2010/12
N2 - Objective: This prospective, two-centre study was designed to evaluate long-term outcomes when using a collagen plug to treat cryptoglandular anal fistulae. Materials and method: Over 3 years, 60 consecutive patients with cryptoglandular fistulae were treated using an anal fistula plug by experienced surgeons. Preoperative, postoperative and follow-up data were collected in a dedicated database. Success was defined as the closure of all fistula openings and the absence of discharge. Faecal incontinence scores were administered at baseline and at 6 months follow-up. Results: Eleven patients had multiple fistula tracts. All fistulae treated in this series were classified as complex. Seventeen fistulae were anterior tracts in females, and the remaining tracts were trans-sphincteric in nature. Thirty-eight tracts were recurrent. Mean operative time was 26∈±∈10 min. No major complications, active sepsis or mortality were observed. Success rate with a mean follow-up of 13 months was 60% of patients and 70% of tracts. Mean time for recurrence was 5.7 months. Two recurrent patients were successfully treated with a redo plug procedure, and five were successfully closed with a post-plug fistulotomy, leading to a global 72% success rate without continence impairment. Of the patients with a minimum follow-up of 6 months (mean, 18.5 months; range, 6-34 months), 29 in 32 (90.6%) were healed at final evaluation. In these patients, the mean preoperative CCF incontinence score was 0.73. This was reduced to 0.14 at 6-month follow-up. The mean reduction of CCF incontinence score was -0.6 (95% CI, 1.3 to -0.1; p = 0.01). Conclusion: Fistula tract treatment with the anal fistula plug is a safe and viable surgical option that should be offered to complex fistula patients. The reasons and risk factors for recurrence remain to be explored.
AB - Objective: This prospective, two-centre study was designed to evaluate long-term outcomes when using a collagen plug to treat cryptoglandular anal fistulae. Materials and method: Over 3 years, 60 consecutive patients with cryptoglandular fistulae were treated using an anal fistula plug by experienced surgeons. Preoperative, postoperative and follow-up data were collected in a dedicated database. Success was defined as the closure of all fistula openings and the absence of discharge. Faecal incontinence scores were administered at baseline and at 6 months follow-up. Results: Eleven patients had multiple fistula tracts. All fistulae treated in this series were classified as complex. Seventeen fistulae were anterior tracts in females, and the remaining tracts were trans-sphincteric in nature. Thirty-eight tracts were recurrent. Mean operative time was 26∈±∈10 min. No major complications, active sepsis or mortality were observed. Success rate with a mean follow-up of 13 months was 60% of patients and 70% of tracts. Mean time for recurrence was 5.7 months. Two recurrent patients were successfully treated with a redo plug procedure, and five were successfully closed with a post-plug fistulotomy, leading to a global 72% success rate without continence impairment. Of the patients with a minimum follow-up of 6 months (mean, 18.5 months; range, 6-34 months), 29 in 32 (90.6%) were healed at final evaluation. In these patients, the mean preoperative CCF incontinence score was 0.73. This was reduced to 0.14 at 6-month follow-up. The mean reduction of CCF incontinence score was -0.6 (95% CI, 1.3 to -0.1; p = 0.01). Conclusion: Fistula tract treatment with the anal fistula plug is a safe and viable surgical option that should be offered to complex fistula patients. The reasons and risk factors for recurrence remain to be explored.
KW - Anal fistula
KW - Anal fistula plug
KW - Bioprosthetics
KW - Cryptoglandular
KW - Incontinence
UR - http://www.scopus.com/inward/record.url?scp=78149410625&partnerID=8YFLogxK
U2 - 10.1007/s00384-010-0957-y
DO - 10.1007/s00384-010-0957-y
M3 - Article
C2 - 20556403
AN - SCOPUS:78149410625
VL - 25
SP - 1487
EP - 1493
IS - 12
ER -